Who are we?
Virology Consult Ltd., was founded in 2019 by Dr Rob Lambkin-Williams and is proud to have evolved from Retroscreen Virology Ltd. (subsequently renamed hVIVO Services Ltd and now part of Orphan PLC) …..[more]
The Team is a consortium of experts in virology and supporting service, use this contact form to get in touch.
Curated Latest Virology News
Latest Post
- No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
- Herd Immunity and Vaccination of Children for COVID19
- 4 Unusual Things We’ve Learned About The Coronavirus Since The Start of The Pandemic
- Warwick researchers bid to revolutionise coronavirus testing
- Operation Warp Speed’s opaque choices of COVID-19 vaccines draw Senate scrutiny
- What we (don’t) know about Covid-19’s long-term health effects
- Coronavirus has upended the profit incentives for pharmaceutical research
- The major genetic risk factor for severe COVID-19 is inherited from Neandertals | bioRxiv
- Experimental COVID-19 Vaccine Shows Positive Early Results in Human Trial
- Dominant Coronavirus Strain Appears to Be a Mutated, More Virulent Version, Study Finds
- U.S. Surpasses Global Record For New COVID-19 Cases Recorded In A Day
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial – The Lancet
- One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results?
- For This Fourth of July, Officials Say Celebrate Freedom by Staying Home – The New York Times
- Emerging flu virus in Chinese pigs has pandemic potential, researchers say
- How a British team discovered the first life-saving coronavirus drug
- Coronavirus Live Updates: As Officials Fight Vaccine Skepticism, Fauci Warns U.S. Could Hit 100,000 Daily Cases
- Will the COVID-19 Pandemic Slow Down in the Northern Hemisphere by the Onset of Summer? An Epidemiological Hypothesis
- Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings: A Living Rapid Review
- Pixatimod (PG545), a clinical-stage heparan sulfate mimetic, is a potent inhibitor of the SARS-CoV-2 virus
No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
Rob LW
6th July 2020
Statement from the Chief Investigators of the Randomised Evaluation of…
Read More
Herd Immunity and Vaccination of Children for COVID19
Rob LW
6th July 2020
COVID-19 is an emerging, rapidly evolving situation. Get the latest…
Read More
4 Unusual Things We’ve Learned About The Coronavirus Since The Start of The Pandemic
Rob LW
5th July 2020
Electron Micrograph of SARS-CoV-2. (National Institute of Allergy and Infectious…
Read More
Warwick researchers bid to revolutionise coronavirus testing
Rob LW
4th July 2020
OK, obviously have to declare a bias, as this is…
Read More
Operation Warp Speed’s opaque choices of COVID-19 vaccines draw Senate scrutiny
Rob LW
4th July 2020
During a hearing on COVID-19 vaccines, Francis Collins, director of…
Read More
What we (don’t) know about Covid-19’s long-term health effects
Rob LW
4th July 2020
Some people with Covid-19 are sick long after the infection…
Read More
Coronavirus has upended the profit incentives for pharmaceutical research
Rob LW
4th July 2020
It costs serious money to test coronavirus treatments like remdesivir….
Read More
The major genetic risk factor for severe COVID-19 is inherited from Neandertals | bioRxiv
Rob LW
4th July 2020
Click here to view original web page at The major…
Read More